Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10434)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2018 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Heras SCDL, Martínez-Balibrea E. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer. World J Gastroenterol 2018; 24(42): 4738-4749 [PMID: 30479461 DOI: 10.3748/wjg.v24.i42.4738] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i42/4738.htm |
| Number | Citing Articles |
| 1 |
Zerrin Isik, Asım Leblebici, Ezgi Demir Karaman, Caner Karaca, Hulya Ellidokuz, Altug Koc, Ender Berat Ellidokuz, Yasemin Basbinar, Sripathi M. Sureban. In silico identification of novel biomarkers for key players in transition from normal colon tissue to adenomatous polyps. PLOS ONE 2022; 17(4): e0267973 doi: 10.1371/journal.pone.0267973
|
| 2 |
Kaisheng Liu, Minshan Lai, Shaoxiang Wang, Kai Zheng, Shouxia Xie, Xiao Wang. Construction of a CXC Chemokine-Based Prediction Model for the Prognosis of Colon Cancer. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/6107865
|
| 3 |
Jarosław Wierzbicki, Iwona Bednarz-Misa, Łukasz Lewandowski, Artur Lipiński, Anna Kłopot, Katarzyna Neubauer, Małgorzata Krzystek-Korpacka. Macrophage Inflammatory Proteins (MIPs) Contribute to Malignant Potential of Colorectal Polyps and Modulate Likelihood of Cancerization Associated with Standard Risk Factors. International Journal of Molecular Sciences 2024; 25(3): 1383 doi: 10.3390/ijms25031383
|
| 4 |
Lei Yu, Miao-Miao Zhang, Ji-Guang Hou. Molecular and cellular pathways in colorectal cancer: apoptosis, autophagy and inflammation as key players. Scandinavian Journal of Gastroenterology 2022; 57(11): 1279 doi: 10.1080/00365521.2022.2088247
|
| 5 |
Natalia Zeber-Lubecka, Maria Kulecka, Katarzyna Załęska-Oracka, Michalina Dąbrowska, Aneta Bałabas, Ewa E. Hennig, Magdalena Szymanek-Szwed, Michał Mikula, Beata Jurkiewicz, Jerzy Ostrowski. Gene Expression-Based Functional Differences between the Bladder Body and Trigonal Urothelium in Adolescent Female Patients with Micturition Dysfunction. Biomedicines 2022; 10(6): 1435 doi: 10.3390/biomedicines10061435
|
| 6 |
Yanhua Jing, Fengjiao Wang, Ke Zhang, Zhen Chen. Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01246-4
|
| 7 |
Sara Pączek, Marta Łukaszewicz-Zając, Mariusz Gryko, Piotr Mroczko, Agnieszka Kulczyńska-Przybik, Barbara Mroczko. CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression. International Journal of Molecular Sciences 2020; 21(6): 2040 doi: 10.3390/ijms21062040
|
| 8 |
Fangyuan Jiang, Jianhui Zhao, Jing Sun, Wenxi Chen, Yuyuan Zhao, Siyun Zhou, Shuai Yuan, Maria Timofeeva, Philip J. Law, Susanna C. Larsson, Dong Chen, Richard S. Houlston, Malcolm G. Dunlop, Evropi Theodoratou, Xue Li. Impact of ambient air pollution on colorectal cancer risk and survival: insights from a prospective cohort and epigenetic Mendelian randomization study. eBioMedicine 2024; 103: 105126 doi: 10.1016/j.ebiom.2024.105126
|
| 9 |
Kennady Bullock, Ann Richmond. Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy. Cancers 2021; 13(24): 6293 doi: 10.3390/cancers13246293
|
| 10 |
Dao-Fang Ding, Yan Xue, Jun-Peng Zhang, Zeng-Qiao Zhang, Wen-Yao Li, Yue-Long Cao, Jian-Guang Xu. Similarities and differences between rat and mouse chondrocyte gene expression induced by IL-1β. Journal of Orthopaedic Surgery and Research 2022; 17(1) doi: 10.1186/s13018-021-02889-2
|
| 11 |
Sandrine Gulberti, Xianqing Mao, Catherine Bui, Sylvie Fournel-Gigleux. The role of heparan sulfate maturation in cancer: A focus on the 3O-sulfation and the enigmatic 3O-sulfotransferases (HS3STs). Seminars in Cancer Biology 2020; 62: 68 doi: 10.1016/j.semcancer.2019.10.009
|
| 12 |
Julia Varga, Adele Nicolas, Valentina Petrocelli, Marina Pesic, Abdelrahman Mahmoud, Birgitta E. Michels, Emre Etlioglu, Diego Yepes, Björn Häupl, Paul K. Ziegler, Katrin Bankov, Peter J. Wild, Stefan Wanninger, Hind Medyouf, Henner F. Farin, Sabine Tejpar, Thomas Oellerich, Jürgen Ruland, Christian W. Siebel, Florian R. Greten. AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer. Journal of Experimental Medicine 2020; 217(10) doi: 10.1084/jem.20191515
|
| 13 |
Verónica Ibáňez Gaspar, Simona Catozzi, Camille Ternet, Philip J. Luthert, Christina Kiel. Analysis of Ras-effector interaction competition in large intestine and colorectal cancer context. Small GTPases 2021; 12(3): 209 doi: 10.1080/21541248.2020.1724596
|
| 14 |
Weiyang Cai, Wenming Bao, Shengwei Chen, Yan Yang, Yanyan Li. Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02378-w
|
| 15 |
Xu Shi, Jun Yu, Chen Lu, Qian Luo, Caihong Xu, Jie Li, Wei Wang. Screening of the shared pathogenic genes of ulcerative colitis and colorectal cancer by integrated bioinformatics analysis. Journal of Cellular and Molecular Medicine 2024; 28(5) doi: 10.1111/jcmm.17878
|
| 16 |
Yaoqing Li, Chuchu Xu, Renjun Zhu, Liyijing Shen, Gengyuan Hu, Kelong Tao, Feng Tao, Zengxin Lu, Guolin Zhang. TIMP-2 as a predictive biomarker in 5-Fu-resistant colorectal cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(10): 7235 doi: 10.1007/s00432-023-04670-w
|
| 17 |
Marta Łukaszewicz-Zając, Sara Pączek, Piotr Mroczko, Agnieszka Kulczyńska-Przybik. <p>The Significance of CXCL1 and CXCL8 as Well as Their Specific Receptors in Colorectal Cancer</p>. Cancer Management and Research 2020; : 8435 doi: 10.2147/CMAR.S267176
|
| 18 |
Lanqin Cao, Lai Wei, Qiaoyun Du, Ying Su, Shuzi Ye, Kaihua Liu. Spleen Toxicity of Organophosphorus Flame Retardant TDCPP in Mice and the Related Mechanisms. Toxics 2023; 11(3): 231 doi: 10.3390/toxics11030231
|
| 19 |
Maria Braoudaki, Mohammed Saqif Ahmad, Denis Mustafov, Sara Seriah, Mohammad Naseem Siddiqui, Shoib Sarwar Siddiqui. Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact. Seminars in Cancer Biology 2022; 86: 436 doi: 10.1016/j.semcancer.2022.06.002
|
| 20 |
Chenglin Li, Hanshun Deng, Yanfei Zhou, Yuanshen Ye, Shuizhen Zhao, Shangnan Liang, Shirong Cai, Jincai Lin, Yaolong Tang, Yanyu Wu. Expression and clinical significance of CXC chemokines in the glioblastoma microenvironment. Life Sciences 2020; 261: 118486 doi: 10.1016/j.lfs.2020.118486
|
| 21 |
Mingfu Cui, Yanan Zhao, Zuocong Zhang, Yang Zhao, Songyun Han, Ruijie Wang, Dayong Ding, Xuedong Fang. IL-8, MSPa, MIF, FGF-9, ANG-2 and AgRP collection were identified for the diagnosis of colorectal cancer based on the support vector machine model. Cell Cycle 2021; 20(8): 781 doi: 10.1080/15384101.2021.1903208
|
| 22 |
Mahvash Sadeghi, Sajad Dehnavi, Ali Asadirad, Suowen Xu, Muhammed Majeed, Tannaz Jamialahmadi, Thomas P. Johnston, Amirhossein Sahebkar. Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases. Inflammopharmacology 2023; 31(3): 1069 doi: 10.1007/s10787-023-01136-w
|
| 23 |
Neng Wang, Shengqi Wang, Xuan Wang, Yifeng Zheng, Bowen Yang, Juping Zhang, Bo Pan, Jianli Gao, Zhiyu Wang. Research trends in pharmacological modulation of tumor‐associated macrophages. Clinical and Translational Medicine 2021; 11(1) doi: 10.1002/ctm2.288
|
| 24 |
Wei Song, Tao Fu. Circular RNA-Associated Competing Endogenous RNA Network and Prognostic Nomogram for Patients With Colorectal Cancer. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01181
|
| 25 |
Lijuan Lyu, Yi Zheng, Yun Hong, Meng Wang, Yujiao Deng, Ying Wu, Peng Xu, Si Yang, Shuqian Wang, Jia Yao, Dai Zhang, Yan Guo, Jun Lyu, Zhijun Dai. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer. International Immunopharmacology 2020; 87: 106797 doi: 10.1016/j.intimp.2020.106797
|
| 26 |
Ariana Rueda, Julian I. Mendoza, Lorena Alba-Castellon, Eloi Parladé, Eric Voltà-Durán, David Paez, Anna Aviño, Ramon Eritja, Esther Vázquez, Antonio Villaverde, Ramón Mangues, Ugutz Unzueta. Site-directed cysteine coupling of disulfide-containing non-antibody carrier proteins (THIOCAPs). Science China Materials 2023; 66(10): 4109 doi: 10.1007/s40843-023-2571-6
|
| 27 |
Xi Yang, Yuanfeng Wei, Feng Sheng, Yirong Xu, Jiao Liu, Ling Gao, Ju Yang, Xinchen Sun, Junxing Huang, Qing Guo. Comprehensive analysis of the prognosis and immune infiltration for CXC chemokines in colorectal cancer. Aging 2021; 13(13): 17548 doi: 10.18632/aging.203245
|
| 28 |
Cong Lu, Jiang Zhu, Xiangjun Chen, Yanjie Hu, Wei Xie, Junxia Yao, Shiang Huang. Risk Stratification in Acute Myeloid Leukemia Using CXCR Gene Signatures: A Bioinformatics Analysis. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.584766
|
| 29 |
Xiaofan Luo, Jiandong Tai, Yuhang Zhao, Pingwei Zhao, Di Sun, Lei Wang. Associations of C‑X‑C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer. Oncology Letters 2022; 24(4) doi: 10.3892/ol.2022.13468
|
| 30 |
Apryl S. Saunders, Dawn E. Bender, Anita L. Ray, Xiangyan Wu, Katherine T. Morris, Salvatore V Pizzo. Colony-stimulating factor 3 signaling in colon and rectal cancers: Immune response and CMS classification in TCGA data. PLOS ONE 2021; 16(2): e0247233 doi: 10.1371/journal.pone.0247233
|
| 31 |
Jing Zhang, Shouguo Huang, Lini Quan, Qiu Meng, Haiyan Wang, Jie Wang, Jin Chen, A.Seval Ozgu-Erdinc. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/8883800
|
| 32 |
Jingxin Zhang, Wenji Hou, Junbo Zuo, Zhenhua Huang, Xin Ding, Xuefeng Bu. CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma. Medicine 2022; 101(42): e31096 doi: 10.1097/MD.0000000000031096
|
| 33 |
Elena V. Svirshchevskaya, Mariya V. Konovalova, Eugene V. Snezhkov, Rimma A. Poltavtseva, Sergey B. Akopov. Chemokine Homeostasis in Healthy Volunteers and during Pancreatic and Colorectal Tumor Growth in Murine Models. Current Issues in Molecular Biology 2022; 44(10): 4987 doi: 10.3390/cimb44100339
|
| 34 |
Tianqing Sang, Wenli Qiu, Wenting Li, Hongli Zhou, Haibin Chen, Hongguang Zhou. The Relationship between Prevention and Treatment of Colorectal Cancer and Cancerous Toxin Pathogenesis Theory Basing on Gut Microbiota. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/7162545
|
| 35 |
McKenzie Crist, Benyamin Yaniv, Sarah Palackdharry, Maria A Lehn, Mario Medvedovic, Timothy Stone, Shuchi Gulati, Vidhya Karivedu, Michael Borchers, Bethany Fuhrman, Audrey Crago, Joseph Curry, Ubaldo Martinez-Outschoorn, Vinita Takiar, Trisha M Wise-Draper. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition. Journal for ImmunoTherapy of Cancer 2022; 10(11): e005632 doi: 10.1136/jitc-2022-005632
|
| 36 |
Subhashini D., Daniel Alex Anand. Psoriasis Comorbidities and Shared Disease Mechanisms – An Investigation using Systems Biology approaches. Research Journal of Pharmacy and Technology 2023; : 863 doi: 10.52711/0974-360X.2023.00147
|
| 37 |
Xinglong Dai, Menghua Zeng, Zhen Huang, Jun Zhang, Zhengqiang Wei, Ziwei Wang, Michele Malaguarnera. A Novel Prognostic Chemokine-Related lncRNAs Signature Associated with Immune Landscape in Colon Adenocarcinoma. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/2823042
|
| 38 |
Caiyun Wu, Cong Ma, Jing Yuan, Pei Zhou. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis. Mathematical Biosciences and Engineering 2021; 18(6): 8201 doi: 10.3934/mbe.2021407
|
| 39 |
Lude Zhu, Guolong Zhang, Peiru Wang, Linglin Zhang, Jie Ji, Xiaojing Liu, Zhongxia Zhou, Jingjun Zhao, Xiuli Wang. The effect of C-X-C motif chemokine ligand 13 in cutaneous squamous cell carcinoma treated with aminolevulinic acid-photodynamic therapy. Photodiagnosis and Photodynamic Therapy 2019; 26: 389 doi: 10.1016/j.pdpdt.2019.04.018
|
| 40 |
Ranmali Ranasinghe, Michael Mathai, Anthony Zulli. A synopsis of modern - day colorectal cancer: Where we stand. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(2): 188699 doi: 10.1016/j.bbcan.2022.188699
|
| 41 |
Han Zhang, Chuan Qin, Hua Gan, Xiong Guo, Li Zhang. Construction of an Immunogenomic Risk Score for Prognostication in Colon Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00499
|
| 42 |
Long Li, Wenchao Yao, Sen Yan, Xianghui Dong, Zhenyi Lv, Qingxu Jing, Qiang Wang, Biao Ma, Chenjun Hao, Dongbo Xue, Dawei Wang. Pan-Cancer Analysis of Prognostic and Immune Infiltrates for CXCs. Cancers 2021; 13(16): 4153 doi: 10.3390/cancers13164153
|
| 43 |
Jiafei Liu, Like Qu, Lin Meng, Chengchao Shou. Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1353-2
|
| 44 |
Valentina La Cognata, Giovanna Morello, Maria Guarnaccia, Sebastiano Cavallaro. The multifaceted role of the CXC chemokines and receptors signaling axes in ALS pathophysiology. Progress in Neurobiology 2024; 235: 102587 doi: 10.1016/j.pneurobio.2024.102587
|
| 45 |
Hideo Satsu, Midori Fukumura, Kenji Watari. Taurine 12. Advances in Experimental Medicine and Biology 2022; 1370: 41 doi: 10.1007/978-3-030-93337-1_4
|
| 46 |
Shengnan Yu, Ming Yi, Linping Xu, Shuang Qin, Anping Li, Kongming Wu. CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer. Frontiers in Oncology 2020; 9 doi: 10.3389/fonc.2019.01515
|
| 47 |
Naroa Serna, Olivia Cano‐Garrido, Laura Sánchez‐García, Mireia Pesarrodona, Ugutz Unzueta, Alejandro Sánchez‐Chardi, Ramon Mangues, Esther Vázquez, Antonio Villaverde. Engineering Protein Venoms as Self‐Assembling CXCR4‐Targeted Cytotoxic Nanoparticles. Particle & Particle Systems Characterization 2020; 37(6) doi: 10.1002/ppsc.202000040
|
| 48 |
Xin Qi, Donghui Yan, Jiachen Zuo, Rui Wang, Jiajia Chen. Development of a novel chemokine signaling-based multigene signature to predict prognosis and therapeutic response in colorectal cancer. Journal of Zhejiang University-SCIENCE B 2021; 22(12): 1053 doi: 10.1631/jzus.B2100412
|
| 49 |
Jianxia Li, Jianwei Zhang, Huabin Hu, Yue Cai, Jiayu Ling, Zehua Wu, Yanhong Deng. <p>Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients</p>. Cancer Management and Research 2020; : 3301 doi: 10.2147/CMAR.S243490
|
| 50 |
Xiaoqian Zhang, Jian Yang, Qianqian Feng, Liping Gu, Gongzhao Qin, Chen Cheng, Shunyu Hou, Zhouhong Shi. The immune landscape and prognostic analysis of CXCL8 immune‐related genes in cervical squamous cell carcinoma. Environmental Toxicology 2024; doi: 10.1002/tox.24283
|
| 51 |
Ming Li, Ziming Liu, Jia Song, Tian Wang, Hongjie Wang, Yanan Wang, Jiguang Guo. Identification of Down-Regulated ADH1C is Associated With Poor Prognosis in Colorectal Cancer Using Bioinformatics Analysis. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.791249
|
| 52 |
Marta Łukaszewicz-Zając, Monika Zajkowska, Sara Pączek, Agnieszka Kulczyńska-Przybik, Kamil Safiejko, Marcin Juchimiuk, Leszek Kozłowski, Barbara Mroczko. The Significance of CXCL1 and CXCR1 as Potential Biomarkers of Colorectal Cancer. Biomedicines 2023; 11(7): 1933 doi: 10.3390/biomedicines11071933
|
| 53 |
Weina Kong, Gang Zhao, Haixia Chen, Weina Wang, Xiaoqian Shang, Qiannan Sun, Fan Guo, Xiumin Ma. Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02101-9
|
| 54 |
Paulina Lewandowska, Izabela Szczuka, Iwona Bednarz-Misa, Berenika M. Szczęśniak-Sięga, Katarzyna Neubauer, Magdalena Mierzchała-Pasierb, Marek Zawadzki, Wojciech Witkiewicz, Małgorzata Krzystek-Korpacka. Modulating Properties of Piroxicam, Meloxicam and Oxicam Analogues against Macrophage-Associated Chemokines in Colorectal Cancer. Molecules 2021; 26(23): 7375 doi: 10.3390/molecules26237375
|
| 55 |
Anqi Lin, Chang Qi, Mujiao Li, Rui Guan, Evgeny N. Imyanitov, Natalia V. Mitiushkina, Quan Cheng, Zaoqu Liu, Xiaojun Wang, Qingwen Lyu, Jian Zhang, Peng Luo. Deep Learning Analysis of the Adipose Tissue and the Prediction of Prognosis in Colorectal Cancer. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.869263
|
| 56 |
Mahmood Rasool, Peter Natesan Pushparaj, Sajjad Karim. Overexpression of CXCL8 gene in Saudi colon cancer patients. Saudi Journal of Biological Sciences 2021; 28(11): 6045 doi: 10.1016/j.sjbs.2021.09.031
|
| 57 |
Brooke L. Farrugia, James Melrose. The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour. International Journal of Molecular Sciences 2023; 24(18): 14101 doi: 10.3390/ijms241814101
|
| 58 |
Dafeng Xu, Yu Wang, Kailun Zhou, Jincai Wu, Zhensheng Zhang, Jiachao Zhang, Zhiwei Yu, Luzheng Liu, Xiangmei Liu, Bidan Li, Jinfang Zheng. Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis. Bioscience Reports 2020; 40(12) doi: 10.1042/BSR20201087
|
| 59 |
Jianqiao Kong, Song Xu, Peng Zhang, Yun Zhao. CXCL1 promotes immune escape in colorectal cancer by autophagy-mediated MHC-I degradation. Human Immunology 2023; 84(12): 110716 doi: 10.1016/j.humimm.2023.09.002
|
| 60 |
Xingchao Wang, Jianfeng Zhang, Baoying Hu, Fei Qian. High Expression of CSF-1R Predicts Poor Prognosis and CSF-1Rhigh Tumor-Associated Macrophages Inhibit Anti-Tumor Immunity in Colon Adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.850767
|
| 61 |
Kohei Kobatake, Kenichiro Ikeda, Yuichiro Nakata, Norimasa Yamasaki, Akinori Kanai, Yohei Sekino, Kenshiro Takemoto, Takafumi Fukushima, Takashi Babasaki, Hiroyuki Kitano, Keisuke Goto, Tetsutaro Hayashi, Kazuhiro Sentani, Jun Teishima, Osamu Kaminuima, Nobuyuki Hinata. DDX41 expression is associated with tumor necrosis in clear cell renal cell carcinoma and in cooperation with VHL loss leads to worse prognosis. Urologic Oncology: Seminars and Original Investigations 2022; 40(10): 456.e9 doi: 10.1016/j.urolonc.2022.07.001
|
| 62 |
Yan Li, Mingqiang Liang, Yuxiang Lin, Jinxing Lv, Minyan Chen, Peng Zhou, Fangmeng Fu, Chuan Wang. Transcriptional Expressions of CXCL9/10/12/13 as Prognosis Factors in Breast Cancer. Journal of Oncology 2020; 2020: 1 doi: 10.1155/2020/4270957
|
| 63 |
Qi-yuan Lv, Hai-zhou Zou, Yu-yan Xu, Zhen-yong Shao, Ruo-qi Wu, Ke-jie Li, Xia Deng, Dian-na Gu, Hong-xiao Jiang, Meng Su, Chang-lin Zou. Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses. Bioengineered 2021; 12(1): 3711 doi: 10.1080/21655979.2021.1952772
|
| 64 |
Lisheng Zhu, Yangyang Shi, Ying Xiong, Li Ba, Qiuting Li, Mengjun Qiu, Zhenwei Zou, Gang Peng. Emerging self-assembling peptide nanomaterial for anti-cancer therapy. Journal of Biomaterials Applications 2021; 36(5): 882 doi: 10.1177/08853282211027882
|
| 65 |
Haizhou Wang, Fei Xu, Meng Zhang, Jing Liu, Fan Wang, Qiu Zhao. A Prognostic Immunoscore for Relapse-Free Survival Prediction in Colorectal Cancer. DNA and Cell Biology 2020; 39(7): 1181 doi: 10.1089/dna.2020.5490
|
| 66 |
Eric Voltà-Durán, Julieta M. Sánchez, Eloi Parladé, Naroa Serna, Esther Vazquez, Ugutz Unzueta, Antonio Villaverde. The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles. Pharmaceutics 2022; 14(12): 2644 doi: 10.3390/pharmaceutics14122644
|
| 67 |
Hufei Wang, Kangjia Luo, Zilong Guan, Zhi Li, Jun Xiang, Suwen Ou, Yangbao Tao, Songlin Ran, Jinhua Ye, Tianyi Ma, Tianyu Qiao, Zhiming Zhang, Yinghu Jin, Yanni Song, Rui Huang. Identification of the Crucial Role of CCL22 in F. nucleatum-Related Colorectal Tumorigenesis that Correlates With Tumor Microenvironment and Immune Checkpoint Therapy. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.811900
|
| 68 |
Lauren R. Olafson, Anna H. Siddell, Kathryn M. Field, Madeleine Byrnes, Robert W. Rapkins, Benedict Ng, Sheri Nixdorf, Elizabeth H. Barnes, Terrance G. Johns, Sonia Yip, John Simes, Anna K. Nowak, Mark A. Rosenthal, Kerrie L. McDonald. Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial. Journal of Clinical Neuroscience 2019; 70: 157 doi: 10.1016/j.jocn.2019.08.044
|
| 69 |
Chenjia Zhou, Ying Gao, Peilun Ding, Tao Wu, Guang Ji. The role of CXCL family members in different diseases. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01524-9
|
| 70 |
Georgios Aindelis, Angeliki Tiptiri-Kourpeti, Evangeli Lampri, Katerina Spyridopoulou, Eleftheria Lamprianidou, Ioannis Kotsianidis, Petros Ypsilantis, Aglaia Pappa, Katerina Chlichlia. Immune Responses Raised in an Experimental Colon Carcinoma Model Following Oral Administration of Lactobacillus casei. Cancers 2020; 12(2): 368 doi: 10.3390/cancers12020368
|
| 71 |
Roberto Tamma, Tiziana Annese, Domenico Ribatti. The Extracellular Matrix and the Tumor Microenvironment. Biology of Extracellular Matrix 2022; 11: 375 doi: 10.1007/978-3-030-99708-3_14
|
| 72 |
Yun Chen, Yunzhi Feng, Fei Yan, Yaqiong Zhao, Han Zhao, Yue Guo. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.922195
|
| 73 |
Yingying Cao, Nanlin Jiao, Tiantian Sun, Yanru Ma, Xinyu Zhang, Haoyan Chen, Jie Hong, Youwei Zhang. CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.646252
|
| 74 |
Lili Duan, Wanli Yang, Xiaoqian Wang, Wei Zhou, Yujie Zhang, Jinqiang Liu, Hongwei Zhang, Qingchuan Zhao, Liu Hong, Daiming Fan. Advances in prognostic markers for colorectal cancer. Expert Review of Molecular Diagnostics 2019; 19(4): 313 doi: 10.1080/14737159.2019.1592679
|
| 75 |
Qingquan Zeng, Shuolei Sun, Yaxian Li, Xiaoling Li, Zuwei Li, Hao Liang. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment. Frontiers in Oncology 2020; 9 doi: 10.3389/fonc.2019.01555
|
| 76 |
Yang An, Qiang Wang, Guosen Zhang, Fengjie Sun, Lu Zhang, Haojie Li, Yingkun Li, Yanyu Peng, Wan Zhu, Shaoping Ji, Xiangqian Guo. OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00875
|
| 77 |
Hossein Hozhabri, Marziyeh Mazaheri Moghaddam, Madiheh Mazaheri Moghaddam, Ali Mohammadian. A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14610-2
|